本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

21.78
+0.36001.68%
成交量:47.67万
成交额:1,028.32万
市值:27.84亿
市盈率:121.00
高:21.89
开:21.44
低:20.82
收:21.42
52周最高:30.48
52周最低:16.10
股本:1.28亿
流通股本:7,811.99万
量比:0.70
换手率:0.61%
股息:- -
股息率:- -
每股收益(TTM):0.1800
每股收益(LYR):0.1775
净资产收益率:7.48%
总资产收益率:3.53%
市净率:7.52
市盈率(LYR):122.72

数据加载中...

2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities